We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current TOIIW market cap is 710.26k. The company's latest EPS is USD -1.0994 and P/E is -9.99.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 82.04M | 85.79M | 94.67M | 98.58M | 99.9M |
| Operating Income | -13.93M | -15.29M | -17.97M | -16.36M | -13.85M |
| Net Income | -17.42M | -18.75M | -19.89M | -15.48M | -16.11M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 203M | 252.48M | 324.24M |
| Operating Income | -2k | -684k | -45.86M | -81.95M | -77.02M |
| Net Income | -2k | -441k | -10.93M | 152k | -83.07M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 218.35M | 209.24M | 204.53M | 179.6M | 179.18M |
| Total Liabilities | 146.5M | 152.22M | 163.24M | 150.4M | 163.7M |
| Total Equity | 71.85M | 57.03M | 41.3M | 29.21M | 15.48M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 50k | 231.32M | 203.44M | 261.67M | 209.24M |
| Total Liabilities | 27k | 6.57M | 99.28M | 138.49M | 152.22M |
| Total Equity | 23k | 5M | 104.16M | 123.18M | 57.03M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -32.42M | -36.32M | -15.88M | -31.54M | -30.72M |
| Investing | 51.01M | 62.64M | 19.39M | 37.56M | 47.97M |
| Financing | -5.07M | -6.85M | -938k | -3.09M | -3.33M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | N/A | -582k | -32.68M | -61.76M | -36.32M |
| Investing | N/A | -230M | -12.15M | -131.61M | 62.64M |
| Financing | 25k | 231.47M | 154.01M | 92.21M | -6.85M |
| Market Cap | 710.26k |
| Price to Earnings Ratio | -9.99 |
| Price to Sales Ratio | 2.56 |
| Price to Cash Ratio | 24.77 |
| Price to Book Ratio | 14.55 |
| Dividend Yield | - |
| Shares Outstanding | 75.56M |
| Average Volume (1 week) | 14.35k |
| Average Volume (1 Month) | 13.44k |
| 52 Week Change | -95.48% |
| 52 Week High | 0.3699 |
| 52 Week Low | 0.0051 |
| Spread (Intraday) | 0.01 (56.91%) |
| Company Name | Oncology Institute Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://theoncologyinstitute.com |
| Industry | blank checks (6770) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
